Your browser doesn't support javascript.
loading
The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States.
Bartsch, Sarah M; Ferguson, Marie C; McKinnell, James A; O'Shea, Kelly J; Wedlock, Patrick T; Siegmund, Sheryl S; Lee, Bruce Y.
Afiliación
  • Bartsch SM; Sarah M. Bartsch is a project director at Public Health Informatics, Computational, and Operations Research (PHICOR), Graduate School of Public Health and Health Policy, City University of New York, in New York City.
  • Ferguson MC; Marie C. Ferguson is a project director at PHICOR, Graduate School of Public Health and Health Policy, City University of New York.
  • McKinnell JA; James A. McKinnell is an associate professor of medicine in the Infectious Disease Clinical Outcomes Research Unit, Lundquist Institute, Harbor-UCLA Medical Center, in Los Angeles, California.
  • O'Shea KJ; Kelly J. O'Shea is a senior research analyst at PHICOR, Graduate School of Public Health and Health Policy, City University of New York.
  • Wedlock PT; Patrick T. Wedlock is a senior research analyst at PHICOR, Graduate School of Public Health and Health Policy, City University of New York.
  • Siegmund SS; Sheryl S. Siegmund is director of operations at PHICOR, Graduate School of Public Health and Health Policy, City University of New York.
  • Lee BY; Bruce Y. Lee (bruceleemdmba@gmail.com) is a professor of health policy and management at the Graduate School of Public Health and Health Policy and executive director of PHICOR, both at the City University of New York.
Health Aff (Millwood) ; 39(6): 927-935, 2020 06.
Article en En | MEDLINE | ID: mdl-32324428
ABSTRACT
With the coronavirus disease 2019 (COVID-19) pandemic, one of the major concerns is the direct medical cost and resource use burden imposed on the US health care system. We developed a Monte Carlo simulation model that represented the US population and what could happen to each person who got infected. We estimated resource use and direct medical costs per symptomatic infection and at the national level, with various "attack rates" (infection rates), to understand the potential economic benefits of reducing the burden of the disease. A single symptomatic COVID-19 case could incur a median direct medical cost of $3,045 during the course of the infection alone. If 80 percent of the US population were to get infected, the result could be a median of 44.6 million hospitalizations, 10.7 million intensive care unit (ICU) admissions, 6.5 million patients requiring a ventilator, 249.5 million hospital bed days, and $654.0 billion in direct medical costs over the course of the pandemic. If 20 percent of the US population were to get infected, there could be a median of 11.2 million hospitalizations, 2.7 million ICU admissions, 1.6 million patients requiring a ventilator, 62.3 million hospital bed days, and $163.4 billion in direct medical costs over the course of the pandemic.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neumonía Viral / Brotes de Enfermedades / Costos de la Atención en Salud / Costos de Hospital / Infecciones por Coronavirus / Pandemias / Recursos en Salud Tipo de estudio: Health_economic_evaluation / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Health Aff (Millwood) Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neumonía Viral / Brotes de Enfermedades / Costos de la Atención en Salud / Costos de Hospital / Infecciones por Coronavirus / Pandemias / Recursos en Salud Tipo de estudio: Health_economic_evaluation / Risk_factors_studies Límite: Female / Humans / Male País/Región como asunto: America do norte Idioma: En Revista: Health Aff (Millwood) Año: 2020 Tipo del documento: Article